4//SEC Filing
Hunt Hazel 4
Accession 0000950170-23-040803
CIK 0001088856other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 6:15 PM ET
Size
8.3 KB
Accession
0000950170-23-040803
Insider Transaction Report
Form 4
Hunt Hazel
Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock option (right to buy)
2023-08-08−50,000→ 0 totalExercise: $3.02Exp: 2024-02-06→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2023-08-08$3.02/sh+50,000$151,000→ 123,146 total - Tax Payment
Common Stock
2023-08-08$30.48/sh−29,545$900,532→ 93,601 total
Footnotes (2)
- [F1]These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on February 6, 2024.
- [F2]Fully exercisable.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001698307
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 6:15 PM ET
- Size
- 8.3 KB